Ann: Dimerix Licenses DMX-200 in the US, page-408

  1. 13,823 Posts.
    lightbulb Created with Sketch. 2940
    This is no time to be selling.

    Amicus Therapeutics' DD was pretty thorough. They gained access to blinded data from the March 2024 interim and liked what they saw enough to commit US$30M upfront!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
52.0¢
Change
0.010(1.96%)
Mkt cap ! $297.1M
Open High Low Value Volume
51.0¢ 52.0¢ 50.0¢ $549.1K 1.082M

Buyers (Bids)

No. Vol. Price($)
3 10154 51.5¢
 

Sellers (Offers)

Price($) Vol. No.
52.0¢ 46951 3
View Market Depth
Last trade - 12.33pm 17/06/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.